Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Perinatal dysfunction of innate immunity in cystic fibrosis. Science Translational Medicine , 2025; 17 (782) DOI: 10.1126/scitranslmed.adk9145 Cite This Page : ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...
News Medical on MSN4d
Early immune system changes contribute to lung damage in cystic fibrosisDespite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...
Skin fibrosis is an often-painful condition wherein the skin thickens and hardens, making it difficult to move. And with no effective treatments currently available, patients are left with few avenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback